6801 - 6850 of 8399 Results
Title
Year
- Model-Based Comparison of Deep Brain Stimulation Array Functionality with Varying Number of Radial Electrodes and Machine Learning Feature Sets2016OPENTitle: Model-Based Comparison of Deep Brain Stimulation Array Functionality with Varying Number of Radial Electrodes and Machine Learning Feature SetsJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2016.00058Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncom.2016.00058/pdfCitation Count: 40
- Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease2016OPENTitle: Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 87Issue #: 10Start Page: 1112End Page: 1122Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2015-312690Best OA location URL: https://europepmc.org/articles/pmc5154297?pdf=renderCitation Count: 36
-
OPENTitle: Scheduled, intermittent stimulation of the thalamus reduces tics in Tourette syndromeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 29Issue #:Start Page: 35End Page: 41Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.05.033Best OA location URL: https://europepmc.org/articles/pmc4969169?pdf=renderCitation Count: 27
- Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease2016OPENTitle: Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-016-0610-7Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-016-0610-7Citation Count: 54
- Physiological, pathological, and engineered cell identity reprogramming in the central nervous system2016RESTRICTEDTitle: Physiological, pathological, and engineered cell identity reprogramming in the central nervous systemJournal Name: WIREs Developmental BiologyPublisher: WileyVol: 5Issue #: 4Start Page: 499End Page: 517Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/wdev.234Best OA location URL: https://europepmc.org/articles/pmc4911333?pdf=renderCitation Count: 7
- Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait?2016OPENTitle: Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait?Journal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 11Start Page: 1711End Page: 1719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26665Best OA location URL: https://europepmc.org/articles/pmc5115956?pdf=renderCitation Count: 41
-
RESTRICTEDTitle: The mitochondrial kinase PINK1: functions beyond mitophagyJournal Name: Journal of NeurochemistryPublisher: WileyVol: 139Issue #: S1Start Page: 232End Page: 239Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.13655Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13655Citation Count: 77
- Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s Disease2016RESTRICTEDTitle: Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 13Issue #: 3Start Page: 635End Page: 646Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0449-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0449-z.pdfCitation Count: 17
-
RESTRICTEDTitle: Neuroscience Training for the 21st CenturyJournal Name: NeuronPublisher: Elsevier BVVol: 90Issue #: 5Start Page: 917End Page: 926Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2016.05.030Best OA location URL: http://www.cell.com/article/S0896627316302094/pdfCitation Count: 59
- Structural Brain Alterations Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s Disease2016OPENTitle: Structural Brain Alterations Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s DiseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep26782Best OA location URL: https://www.nature.com/articles/srep26782.pdfCitation Count: 117
-
OPENTitle: Two-Pore Channels and Parkinson's Disease: Where's the Link?Journal Name: MessengerPublisher: American Scientific PublishersVol: 5Issue #: 1Start Page: 67End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1166/msr.2016.1051Best OA location URL: https://europepmc.org/articles/pmc5436604?pdf=renderCitation Count: 7
-
OPENTitle: Histone H3 acetylation in the postmortem Parkinson’s disease primary motor cortexJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 627Issue #:Start Page: 121End Page: 125Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2016.05.060Best OA location URL: https://europepmc.org/articles/pmc5067161?pdf=renderCitation Count: 55
- A review of disease progression models of Parkinson's disease and applications in clinical trials2016RESTRICTEDTitle: A review of disease progression models of Parkinson's disease and applications in clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 947End Page: 956Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26644Best OA location URL: https://europepmc.org/articles/pmc4931998?pdf=renderCitation Count: 47
- JUMPg: An Integrative Proteogenomics Pipeline Identifying Unannotated Proteins in Human Brain and Cancer Cells2016OPENTitle: JUMPg: An Integrative Proteogenomics Pipeline Identifying Unannotated Proteins in Human Brain and Cancer CellsJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 15Issue #: 7Start Page: 2309End Page: 2320Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.6b00344Best OA location URL: https://europepmc.org/articles/pmc5033046?pdf=renderCitation Count: 83
-
RESTRICTEDTitle: Motor subtype in Parkinson's disease: Different disorders or different stages of disease?Journal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 957End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26657Citation Count: 91
- Cerebrospinal Fluid Amyloid β<sub>1-42</sub>, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson’s Disease2016RESTRICTEDTitle: Cerebrospinal Fluid Amyloid β<sub>1-42</sub>, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson’s DiseaseJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 9Issue #: 2Start Page: 89End Page: 96Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.16017Best OA location URL: https://doi.org/10.14802/jmd.16017Citation Count: 20
-
OPENTitle: Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in VivoJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 11Issue #: 8Start Page: 2105End Page: 2111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.6b00217Best OA location URL: https://europepmc.org/articles/pmc4992440?pdf=renderCitation Count: 66
- Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease2016OPENTitle: Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's DiseaseJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 25Issue #: 18Start Page: 967End Page: 982Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1089/ars.2015.6598Best OA location URL: https://www.liebertpub.com/doi/pdf/10.1089/ars.2015.6598Citation Count: 38
-
RESTRICTEDTitle: Vagal neurocircuitry and its influence on gastric motilityJournal Name: Nature Reviews Gastroenterology & HepatologyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 7Start Page: 389End Page: 401Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrgastro.2016.76Best OA location URL: https://europepmc.org/articles/pmc5605144?pdf=renderCitation Count: 201
-
OPENTitle: Inflammatory profile in LRRK2-associated prodromal and clinical PDJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-016-0588-5Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-016-0588-5Citation Count: 66
- A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease2016RESTRICTEDTitle: A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1373End Page: 1380Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26659Citation Count: 126
-
OPENTitle: Cautionary optimism: caffeine and Parkinson’s disease riskJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-016-0037-8Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-016-0037-8Citation Count: 5
-
OPENTitle: LRRK2 Regulates Voltage-Gated Calcium Channel FunctionJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2016.00035Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2016.00035/pdfCitation Count: 51
- Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensor2016RESTRICTEDTitle: Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensorJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 263Issue #: 8Start Page: 1544End Page: 1551Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-016-8164-6Citation Count: 46
- Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease2016OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: https://europepmc.org/articles/pmc5410378?pdf=renderCitation Count: 25
- Parkinson's disease-related network topographies characterized with resting state functional MRI2016OPENTitle: Parkinson's disease-related network topographies characterized with resting state functional MRIJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 2Start Page: 617End Page: 630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23260Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118197Citation Count: 68
-
OPENTitle: Central Hypoventilation in Progressive Supranuclear PalsyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 1Start Page: 42End Page: 45Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12348Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12348Citation Count: 6
- Pure Autonomic Failure Versus Prodromal Dysautonomia in Parkinson's Disease: Insights from the Bedside2016OPENTitle: Pure Autonomic Failure Versus Prodromal Dysautonomia in Parkinson's Disease: Insights from the BedsideJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 1Start Page: 141End Page: 144Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12360Citation Count: 11
- Dentate nucleus iron deposition is a potential biomarker for tremor‐dominant Parkinson's disease2016OPENTitle: Dentate nucleus iron deposition is a potential biomarker for tremor‐dominant Parkinson's diseaseJournal Name: NMR in BiomedicinePublisher: WileyVol: 30Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/nbm.3554Best OA location URL: https://europepmc.org/articles/pmc4906439?pdf=renderCitation Count: 54
-
OPENTitle: Predictors of time to initiation of symptomatic therapy in early Parkinson's diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 7Start Page: 482End Page: 494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.317Best OA location URL: https://doi.org/10.1002/acn3.317Citation Count: 26
-
OPENTitle: Neurogenesis in Cancun: where science meets the seaJournal Name: DevelopmentPublisher: The Company of BiologistsVol: 143Issue #: 10Start Page: 1649End Page: 1654Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dev.138412Best OA location URL: https://dev.biologists.org/content/develop/143/10/1649.full.pdfCitation Count: 0
-
RESTRICTEDTitle: Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseasesJournal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1237End Page: 1245Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728222.2016.1182990Best OA location URL: https://europepmc.org/articles/pmc5315368?pdf=renderCitation Count: 42
-
OPENTitle: Analysis of Mitochondrial haemoglobin in Parkinson's disease brainJournal Name: MitochondrionPublisher: Elsevier BVVol: 29Issue #:Start Page: 45End Page: 52Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mito.2016.05.001Best OA location URL: https://doi.org/10.1016/j.mito.2016.05.001Citation Count: 26
- Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analytics2016OPENTitle: Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analyticsJournal Name: mHealthPublisher: AME Publishing CompanyVol: 2Issue #:Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.21037/mhealth.2016.04.02Best OA location URL: https://europepmc.org/articles/pmc5344108?pdf=renderCitation Count: 34
- Discovery and characterization of a novel series of N -phenylsulfonyl-1 H -pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu 4 )2016OPENTitle: Discovery and characterization of a novel series of N -phenylsulfonyl-1 H -pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu 4 )Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 13Start Page: 2984End Page: 2987Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.05.029Best OA location URL: https://europepmc.org/articles/pmc4955388?pdf=renderCitation Count: 5
- LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias2016OPENTitle: LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesiasJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-016-0234-2Best OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-016-0234-2Citation Count: 13
-
OPENTitle: Normative data for subcortical regional volumes over the lifetime of the adult human brainJournal Name: NeuroImagePublisher: Elsevier BVVol: 137Issue #:Start Page: 9End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuroimage.2016.05.016Best OA location URL: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdfCitation Count: 123
-
OPENTitle: Increased 5-hydroxymethylation levels in the sub ventricular zone of the Alzheimer's brainJournal Name: NeuroepigeneticsPublisher: Elsevier BVVol: 6Issue #:Start Page: 26End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nepig.2016.04.002Best OA location URL: https://doi.org/10.1016/j.nepig.2016.04.002Citation Count: 11
-
RESTRICTEDTitle: Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 45Issue #:Start Page: 212.e13End Page: 212.e17Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.04.023Best OA location URL: http://hdl.handle.net/20.500.11794/13593Citation Count: 48
- How can rAAV‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?2016RESTRICTEDTitle: How can rAAV‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?Journal Name: Journal of NeurochemistryPublisher: WileyVol: 139Issue #: S1Start Page: 131End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.13627Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13627Citation Count: 81
- The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action2016RESTRICTEDTitle: The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of actionJournal Name: Drug Discovery TodayPublisher: Elsevier BVVol: 21Issue #: 5Start Page: 802End Page: 818Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.drudis.2016.01.013Best OA location URL: https://doi.org/10.1016/j.drudis.2016.01.013Citation Count: 246
- Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regeneration2016OPENTitle: Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regenerationJournal Name: Acta BiomaterialiaPublisher: Elsevier BVVol: 38Issue #:Start Page: 44End Page: 58Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.actbio.2016.04.021Best OA location URL: https://europepmc.org/articles/pmc5457669?pdf=renderCitation Count: 80
- Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy2016OPENTitle: Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 12Start Page: 2915End Page: 2919Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.04.041Best OA location URL: https://europepmc.org/articles/pmc4899947?pdf=renderCitation Count: 3
-
RESTRICTEDTitle: How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 28Issue #:Start Page: 62End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.04.027Citation Count: 157
-
OPENTitle: Morphological Alterations in the Thalamus, Striatum, and Pallidum in Autism Spectrum DisorderJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 41Issue #: 11Start Page: 2627End Page: 2637Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/npp.2016.64Best OA location URL: https://www.nature.com/articles/npp201664.pdfCitation Count: 139
-
RESTRICTEDTitle: Technology in Parkinson's disease: Challenges and opportunitiesJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1272End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26642Best OA location URL: http://minerva-access.unimelb.edu.au/bitstreams/9b88ef9a-46cf-56a6-adcc-40327184fd3c/downloadCitation Count: 477
- shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity2016OPENTitle: shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and ToxicityJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e1005995End Page: e1005995Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1005995Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1005995&type=printableCitation Count: 78
- A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid2016OPENTitle: A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal FluidJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 4Start Page: e0153564End Page: e0153564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0153564Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0153564&type=printableCitation Count: 5
- The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort2016OPENTitle: The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohortJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 6Start Page: 924End Page: 932Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.26613Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.26613Citation Count: 53
- Free‐water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO‐B inhibitor2016OPENTitle: Free‐water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO‐B inhibitorJournal Name: Human Brain MappingPublisher: WileyVol: 37Issue #: 8Start Page: 2894End Page: 2903Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23213Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945383Citation Count: 37